顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバル加齢性黄斑変性症市場規模、主要企業シェア、ランキング分析レポート【2025年版】

グローバル加齢性黄斑変性症市場規模、主要企業シェア、ランキング分析レポート【2025年版】

Age Related Macular Degeneration Drug - Global and China Top Players Market Share and Ranking 2025
  • レポートID：
    29941
  • 発表時期：
    2025-01-09
  • レポート形式：
    PDF
  • 産業カテゴリー：
    薬品及びサプリメント
  • レポート言語：
    英語、日本語
  • ページ数：
    91
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の加齢性黄斑変性症市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から加齢性黄斑変性症市場を分析し、需要構造と成長特性を明確化します。
加齢性黄斑変性症市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、加齢性黄斑変性症に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要加齢性黄斑変性症市場の統計
2025年世界市場規模：9204百万米ドル
2026年世界市場規模：9693百万米ドル
2032年予測市場規模：13130百万米ドル
2026–2032年予測期間CAGR：5.5%
本レポートは加齢性黄斑変性症市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
加齢性黄斑変性症市場の主要企業には以下が含まれます：
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma 

製品別
Lucentis
Eylea
Avastin
Others 

アプリケーション別
Hospitals
Clinics
Others 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
加齢性黄斑変性症市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
加齢性黄斑変性症市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に加齢性黄斑変性症市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に加齢性黄斑変性症市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、加齢性黄斑変性症市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、加齢性黄斑変性症市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
加齢性黄斑変性症市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 加齢性黄斑変性症市場の全体像と成長見通し
加齢性黄斑変性症市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が加齢性黄斑変性症市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
加齢性黄斑変性症産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
加齢性黄斑変性症市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から加齢性黄斑変性症市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
加齢性黄斑変性症市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
加齢性黄斑変性症市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Age Related Macular Degeneration Drug should grow from US$ 9204 million in 2024 to US$ 13130 million by 2031, with a CAGR of 5.5% for the period of 2025-2031.

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.

The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.

This report studies and analyses global Age Related Macular Degeneration Drug status and future trends, helps the client to determine the Age Related Macular Degeneration Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Age Related Macular Degeneration Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Age Related Macular Degeneration Drug market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Age Related Macular Degeneration Drug sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Age Related Macular Degeneration Drug sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Age Related Macular Degeneration Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Age Related Macular Degeneration Drug key producing regions, capacity, production, and year over year growth
(6) Age Related Macular Degeneration Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Regeneron Pharmaceuticals
    Bayer HealthCare
    Novartis
    Roche
    Kanghong Pharma

Market segment by Type, covers
    Lucentis
    Eylea
    Avastin
    Others

Market segment by Application, can be divided into
    Hospitals
    Clinics
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Age Related Macular Degeneration Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Age Related Macular Degeneration Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Age Related Macular Degeneration Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Age Related Macular Degeneration Drug, percent & CAGR, 2020-2031
Chapter 5: Age Related Macular Degeneration Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Age Related Macular Degeneration Drug Definition
    1.2 Global Age Related Macular Degeneration Drug Market Size and Forecast
        1.2.1 By Consumption Value, Global Age Related Macular Degeneration Drug Market Size, 2020-2031
        1.2.2 By Sales Quantity, Global Age Related Macular Degeneration Drug Market Size, 2020-2031
        1.2.3 Global Age Related Macular Degeneration Drug Average Selling Price (ASP), 2020-2031
    1.3 China Age Related Macular Degeneration Drug Market Size and Forecast
        1.3.1 By Consumption Value, China Age Related Macular Degeneration Drug Market Size, 2020-2031
        1.3.2 By Sales Quantity, China Age Related Macular Degeneration Drug Market Size, 2020-2031
        1.3.3 China Age Related Macular Degeneration Drug Average Selling Price (ASP), 2020-2031
    1.4 Share of China Age Related Macular Degeneration Drug Market with Respect to the Global Market
        1.4.1 By Consumption Value, China Age Related Macular Degeneration Drug Market Share in Global, 2020-2031
        1.4.2 By Sales Quantity, China Age Related Macular Degeneration Drug Market Share in Global, 2020-2031
        1.4.3 Age Related Macular Degeneration Drug Market Size: China VS Global, 2020-2031
    1.5 Age Related Macular Degeneration Drug Market Dynamics
        1.5.1 Age Related Macular Degeneration Drug Market Drivers
        1.5.2 Age Related Macular Degeneration Drug Market Restraints
        1.5.3 Age Related Macular Degeneration Drug Industry Trends
        1.5.4 Age Related Macular Degeneration Drug Industry Policy
2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Age Related Macular Degeneration Drug, Global Market Share by Company, 2020-2025
    2.2 By Sales Quantity of Age Related Macular Degeneration Drug, Global Market Share by Company, 2020-2025
    2.3 Age Related Macular Degeneration Drug Average Selling Price (ASP) by Company, 2020-2025
    2.4 Global Age Related Macular Degeneration Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Age Related Macular Degeneration Drug Concentration Ratio
    2.6 Global Age Related Macular Degeneration Drug Mergers & Acquisitions, Expansion Plans
    2.7 Global Age Related Macular Degeneration Drug Manufacturers Product Type
    2.8 Head Office and Age Related Macular Degeneration Drug Production Site of Key Manufacturer
    2.9 Age Related Macular Degeneration Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
    3.1 By Revenue of Age Related Macular Degeneration Drug, China Market Share by Company, 2020-2025
    3.2 By Sales Quantity of Age Related Macular Degeneration Drug, China Market Share by Company, 2020-2025
    3.3 China Age Related Macular Degeneration Drug Age Related Macular Degeneration Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
    4.1 Global Age Related Macular Degeneration Drug Capacity, Output and Capacity Utilization, 2020-2031
    4.2 Global Age Related Macular Degeneration Drug Capacity by Region
    4.3 Global Age Related Macular Degeneration Drug Production & Forecast by Region, 2020 VS 2024 VS 2031
    4.4 Global Age Related Macular Degeneration Drug Production by Region, 2020-2031
    4.5 Global Age Related Macular Degeneration Drug Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
    5.1 Age Related Macular Degeneration Drug Industry Chain
    5.2 Age Related Macular Degeneration Drug Upstream Analysis
        5.2.1 Age Related Macular Degeneration Drug Core Raw Materials
        5.2.2 Main Manufacturers of Age Related Macular Degeneration Drug Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Age Related Macular Degeneration Drug Production Mode
    5.6 Age Related Macular Degeneration Drug Procurement Model
    5.7 Age Related Macular Degeneration Drug Industry Sales Model and Sales Channels
        5.7.1 Age Related Macular Degeneration Drug Sales Model
        5.7.2 Age Related Macular Degeneration Drug Typical Distributors
6 Sights by Product Type
    6.1 Age Related Macular Degeneration Drug Classification
        6.1.1 Lucentis
        6.1.2 Eylea
        6.1.3 Avastin
        6.1.4 Others
    6.2 by Type, Global Age Related Macular Degeneration Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
    6.3 by Type, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031
    6.4 by Type, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031
    6.5 by Type, Global Age Related Macular Degeneration Drug Average Selling Price (ASP), 2020-2031
7 Sights by Application
    7.1 Age Related Macular Degeneration Drug Segment by Application
        7.1.1 Hospitals
        7.1.2 Clinics
        7.1.3 Others
    7.2 by Application, Global Age Related Macular Degeneration Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
    7.3 by Application, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031
    7.4 by Application, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031
    7.5 by Application, Global Age Related Macular Degeneration Drug Price, 2020-2031
8 Sales Sights by Region
    8.1 By Region, Global Age Related Macular Degeneration Drug Consumption Value, 2020 VS 2024 VS 2031
    8.2 By Region, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031
    8.3 By Region, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031
    8.4 North America
        8.4.1 North America Age Related Macular Degeneration Drug Market Size & Forecasts, 2020-2031
        8.4.2 By Country, North America Age Related Macular Degeneration Drug Market Size Market Share
    8.5 Europe
        8.5.1 Europe Age Related Macular Degeneration Drug Market Size & Forecasts, 2020-2031
        8.5.2 By Country, Europe Age Related Macular Degeneration Drug Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Age Related Macular Degeneration Drug Market Size & Forecasts, 2020-2031
        8.6.2 By Country/Region, Asia Pacific Age Related Macular Degeneration Drug Market Size Market Share
    8.7 South America
        8.7.1 South America Age Related Macular Degeneration Drug Market Size & Forecasts, 2020-2031
        8.7.2 By Country, South America Age Related Macular Degeneration Drug Market Size Market Share
    8.8 Middle East & Africa
9 Sales Sights by Country Level
    9.1 By Country, Global Age Related Macular Degeneration Drug Market Size & CAGR, 2020 VS 2024 VS 2031
    9.2 By Country, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031
    9.3 By Country, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031
    9.4 United States
        9.4.1 United States Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.4.2 by Type, United States Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.4.3 by Application, United States Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.5 Europe
        9.5.1 Europe Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.5.2 by Type, Europe Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.5.3 by Application, Europe Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.6 China
        9.6.1 China Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.6.2 by Type, China Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.6.3 by Application, China Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.7 Japan
        9.7.1 Japan Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.7.2 by Type, Japan Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.7.3 by Application, Japan Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.8 South Korea
        9.8.1 South Korea Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.8.2 by Type, South Korea Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.8.3 by Application, South Korea Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.9 Southeast Asia
        9.9.1 Southeast Asia Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.9.2 by Type, Southeast Asia Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.9.3 by Application, Southeast Asia Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.10 India
        9.10.1 India Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.10.2 by Type, India Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.10.3 by Application, India Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Age Related Macular Degeneration Drug Market Size, 2020-2031
        9.11.2 by Type, Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
        9.11.3 by Application, Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
    10.1 Regeneron Pharmaceuticals
        10.1.1 Regeneron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Models, Specifications, and Application
        10.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.1.4 Regeneron Pharmaceuticals Company Profile and Main Business
        10.1.5 Regeneron Pharmaceuticals Recent Developments
    10.2 Bayer HealthCare
        10.2.1 Bayer HealthCare Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Bayer HealthCare Age Related Macular Degeneration Drug Models, Specifications, and Application
        10.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.2.4 Bayer HealthCare Company Profile and Main Business
        10.2.5 Bayer HealthCare Recent Developments
    10.3 Novartis
        10.3.1 Novartis Company Information, Head Office, Market Area, and Industry Position
        10.3.2 Novartis Age Related Macular Degeneration Drug Models, Specifications, and Application
        10.3.3 Novartis Age Related Macular Degeneration Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.3.4 Novartis Company Profile and Main Business
        10.3.5 Novartis Recent Developments
    10.4 Roche
        10.4.1 Roche Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Roche Age Related Macular Degeneration Drug Models, Specifications, and Application
        10.4.3 Roche Age Related Macular Degeneration Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.4.4 Roche Company Profile and Main Business
        10.4.5 Roche Recent Developments
    10.5 Kanghong Pharma
        10.5.1 Kanghong Pharma Company Information, Head Office, Market Area, and Industry Position
        10.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Models, Specifications, and Application
        10.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.5.4 Kanghong Pharma Company Profile and Main Business
        10.5.5 Kanghong Pharma Recent Developments
11 Conclusion
12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Age Related Macular Degeneration Drug Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
 Table 2. Age Related Macular Degeneration Drug Market Restraints
 Table 3. Age Related Macular Degeneration Drug Market Trends
 Table 4. Age Related Macular Degeneration Drug Industry Policy
 Table 5. Global Age Related Macular Degeneration Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
 Table 6. Global Age Related Macular Degeneration Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024
 Table 7. Global Age Related Macular Degeneration Drug Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
 Table 8. Global Age Related Macular Degeneration Drug Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
 Table 9. Global Age Related Macular Degeneration Drug Average Selling Price (ASP) by Company, (2020-2025) & (USD/Unit)
 Table 10. Global Age Related Macular Degeneration Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 11. Global Age Related Macular Degeneration Drug Mergers & Acquisitions, Expansion Plans
 Table 12. Global Age Related Macular Degeneration Drug Manufacturers Product Type
 Table 13. Head Office and Age Related Macular Degeneration Drug Production Site of Key Manufacturer
 Table 14. Age Related Macular Degeneration Drug Capacity of Major Manufacturers and Future Plan
 Table 15. China Age Related Macular Degeneration Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
 Table 16. China Age Related Macular Degeneration Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024
 Table 17. China Age Related Macular Degeneration Drug Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
 Table 18. China Age Related Macular Degeneration Drug Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
 Table 19. Global Age Related Macular Degeneration Drug Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)
 Table 20. Global Age Related Macular Degeneration Drug Production by Region, 2020-2025, (K Units)
 Table 21. Global Age Related Macular Degeneration Drug Production Forecast by Region, 2026-2031, (K Units)
 Table 22. Global Key Players of Age Related Macular Degeneration Drug Upstream (Raw Materials)
 Table 23. Global Age Related Macular Degeneration Drug Typical Customers
 Table 24. Age Related Macular Degeneration Drug Typical Distributors
 Table 25. by Type, Global Age Related Macular Degeneration Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
 Table 26. by Application, Global Age Related Macular Degeneration Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
 Table 27. By Region, Global Age Related Macular Degeneration Drug Consumption Value, 2020 VS 2024 VS 2031, US$ Million
 Table 28. By Region, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031, US$ Million
 Table 29. By Region, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Table 30. By Country, Global Age Related Macular Degeneration Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
 Table 31. By Country, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031, US$ Million
 Table 32. By Country, Global Age Related Macular Degeneration Drug Consumption Value Market Share, 2020-2031
 Table 33. By Country, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Table 34. By Country, Global Age Related Macular Degeneration Drug Sales Quantity Market Share, 2020-2031
 Table 35. Regeneron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
 Table 36. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Models, Specifications, and Application
 Table 37. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025
 Table 38. Regeneron Pharmaceuticals Company Profile and Main Business
 Table 39. Regeneron Pharmaceuticals Recent Developments
 Table 40. Bayer HealthCare Company Information, Head Office, Market Area, and Industry Position
 Table 41. Bayer HealthCare Age Related Macular Degeneration Drug Models, Specifications, and Application
 Table 42. Bayer HealthCare Age Related Macular Degeneration Drug Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025
 Table 43. Bayer HealthCare Company Profile and Main Business
 Table 44. Bayer HealthCare Recent Developments
 Table 45. Novartis Company Information, Head Office, Market Area, and Industry Position
 Table 46. Novartis Age Related Macular Degeneration Drug Models, Specifications, and Application
 Table 47. Novartis Age Related Macular Degeneration Drug Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025
 Table 48. Novartis Company Profile and Main Business
 Table 49. Novartis Recent Developments
 Table 50. Roche Company Information, Head Office, Market Area, and Industry Position
 Table 51. Roche Age Related Macular Degeneration Drug Models, Specifications, and Application
 Table 52. Roche Age Related Macular Degeneration Drug Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025
 Table 53. Roche Company Profile and Main Business
 Table 54. Roche Recent Developments
 Table 55. Kanghong Pharma Company Information, Head Office, Market Area, and Industry Position
 Table 56. Kanghong Pharma Age Related Macular Degeneration Drug Models, Specifications, and Application
 Table 57. Kanghong Pharma Age Related Macular Degeneration Drug Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025
 Table 58. Kanghong Pharma Company Profile and Main Business
 Table 59. Kanghong Pharma Recent Developments


List of Figures
 Figure 1. Age Related Macular Degeneration Drug Picture
 Figure 2. Global Age Related Macular Degeneration Drug Consumption Value, (US$ million) & (2020-2031)
 Figure 3. Global Age Related Macular Degeneration Drug Sales Quantity, (K Units) & (2020-2031)
 Figure 4. Global Age Related Macular Degeneration Drug Average Selling Price (ASP), (2020-2031) & (USD/Unit)
 Figure 5. China Age Related Macular Degeneration Drug Consumption Value, (US$ million) & (2020-2031)
 Figure 6. China Age Related Macular Degeneration Drug Sales Quantity (K Units) & (2020-2031)
 Figure 7. China Age Related Macular Degeneration Drug Average Selling Price (ASP), (USD/Unit) & (2020-2031)
 Figure 8. By Consumption Value, China Age Related Macular Degeneration Drug Market Share of Global, 2020-2031
 Figure 9. By Sales Quantity, China Age Related Macular Degeneration Drug Market Share of Global, 2020-2031
 Figure 10. Global Age Related Macular Degeneration Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
 Figure 11. China Age Related Macular Degeneration Drug Key Participants, Market Share, 2024
 Figure 12. Global Age Related Macular Degeneration Drug Capacity, Production and Capacity Utilization, 2020-2031
 Figure 13. Global Age Related Macular Degeneration Drug Capacity Market Share by Region, 2024 VS 2031
 Figure 14. Global Age Related Macular Degeneration Drug Production Market Share & Forecast by Region, 2020-2031
 Figure 15. Age Related Macular Degeneration Drug Industry Chain
 Figure 16. Age Related Macular Degeneration Drug Procurement Model
 Figure 17. Age Related Macular Degeneration Drug Sales Model
 Figure 18. Age Related Macular Degeneration Drug Sales Channels, Direct Sales, and Distribution
 Figure 19. Lucentis
 Figure 20. Eylea
 Figure 21. Avastin
 Figure 22. Others
 Figure 23. by Type, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031, US$ Million
 Figure 24. by Type, Global Age Related Macular Degeneration Drug Consumption Value Market Share, 2020-2031
 Figure 25. by Type, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 26. by Type, Global Age Related Macular Degeneration Drug Sales Quantity Market Share, 2020-2031
 Figure 27. by Type, Global Age Related Macular Degeneration Drug Average Selling Price (ASP), 2020-2031, (USD/Unit)
 Figure 28. Hospitals
 Figure 29. Clinics
 Figure 30. Others
 Figure 31. by Application, Global Age Related Macular Degeneration Drug Consumption Value, 2020-2031, US$ Million
 Figure 32. by Application, Global Age Related Macular Degeneration Drug Revenue Market Share, 2020-2031
 Figure 33. by Application, Global Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 34. by Application, Global Age Related Macular Degeneration Drug Sales Quantity Market Share, 2020-2031
 Figure 35. by Application, Global Age Related Macular Degeneration Drug Price, 2020-2031, (USD/Unit)
 Figure 36. By Region, Global Age Related Macular Degeneration Drug Consumption Value Market Share, 2020-2031
 Figure 37. By Region, Global Age Related Macular Degeneration Drug Sales Quantity Market Share, 2020-2031
 Figure 38. North America Age Related Macular Degeneration Drug Consumption Value & Forecasts, 2020-2031, US$ Million
 Figure 39. By Country, North America Age Related Macular Degeneration Drug Consumption Value Market Share, 2024
 Figure 40. Europe Age Related Macular Degeneration Drug Consumption Value & Forecasts, 2020-2031, US$ Million
 Figure 41. By Country, Europe Age Related Macular Degeneration Drug Consumption Value Market Share, 2024
 Figure 42. Asia Pacific Age Related Macular Degeneration Drug Consumption Value & Forecasts, 2020-2031, US$ Million
 Figure 43. By Country/Region, Asia Pacific Age Related Macular Degeneration Drug Consumption Value Market Share, 2024
 Figure 44. South America Age Related Macular Degeneration Drug Consumption Value & Forecasts, 2020-2031, US$ Million
 Figure 45. By Country, South America Age Related Macular Degeneration Drug Consumption Value Market Share, 2024
 Figure 46. Middle East & Africa Age Related Macular Degeneration Drug Consumption Value & Forecasts, 2020-2031, US$ Million
 Figure 47. United States Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 48. by Type, United States Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 49. by Application, United States Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 50. Europe Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 51. by Type, Europe Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 52. by Application, Europe Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 53. China Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 54. by Type, China Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 55. by Application, China Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 56. Japan Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 57. by Type, Japan Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 58. by Application, Japan Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 59. South Korea Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 60. by Type, South Korea Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 61. by Application, South Korea Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 62. Southeast Asia Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 63. by Type, Southeast Asia Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 64. by Application, Southeast Asia Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 65. India Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 66. by Type, India Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 67. by Application, India Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 68. Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity, 2020-2031, (K Units)
 Figure 69. by Type, Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 70. by Application, Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity Market Share, 2024 VS 2031
 Figure 71. Research Methodology
 Figure 72. Breakdown of Primary Interviews
 Figure 73. Bottom-up Approaches
 Figure 74. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有